Function (short‐term) DRI scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis
1 finding from 1 review
Quality of life (short‐term) GSI scale from 0 to 10 (higher is worse quality of life). · patients with hip osteoarthritis
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis
1 finding from 1 review
Function (short‐term) Harris function score from: 0 to 47 (higher is better function). · patients with hip osteoarthritis
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with hip osteoarthritis
1 finding from 1 review
Function (short‐term) WOMAC scale from: 0 to 100 (higher is worse function). · patients with hip osteoarthritis
1 finding from 1 review
Intervention not reported
Quality of life: general ‐ average endpoint score (GWB, high score = good) ‐ short term ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Short‐term clinical cure (up to 3 months after start of treatment) (completely cleared short term) · molluscum contagiosum
Imiquimod showed no clear difference in short‐term clinical cure (up to 3 months after start of treatment)… compared with vehicle (moderate certainty).
1 finding from 1 review
Short‐term clinical improvement (up to 3 months after start of treatment) · molluscum contagiosum
Imiquimod showed no clear difference in short‐term clinical improvement (up to 3 months after start of… compared with vehicle (high certainty).
1 finding from 1 review
Short‐term mortality (30‐day or in‐hospital) · people diagnosed with RAAA
Emergency endovascular aneurysm repair showed no clear difference in short‐term mortality (30‐day or in‐hospital) compared with conventional open repair (moderate certainty).
1 finding from 1 review
Death ‐ in all participants ‐ short term · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in death ‐ in all participants ‐ short term compared with long‐acting (oily) chloramphenicol (moderate certainty).
1 finding from 1 review
Clinical failure ‐ in all participants ‐ short term Composite clinical criteria10 · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in clinical failure ‐ in all participants ‐ short term Composite… compared with long‐acting (oily) chloramphenicol (moderate certainty).
1 finding from 1 review
Neurological sequelae ‐ in all participants‐ short term Clinical assessment11 · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in neurological sequelae ‐ in all participants‐ short term Clinical… compared with long‐acting (oily) chloramphenicol (low certainty).
1 finding from 1 review
Adverse events ‐ short term · people suspected to have meningococcal disease (adults and children)
1 finding from 1 review
Leaving the study early · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride changes leaving the study early (any reason, short and medium term) compared with perphenazine (very low certainty).
1 finding from 1 review
Adverse effects: Clinically important general adverse effect ‐ short term (EPSEs requiring medication) · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride changes adverse effects: Clinically important general adverse effect ‐ short… compared with risperidone (very low certainty).
1 finding from 1 review
Leaving the study early · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride changes leaving the study early (any reason, short and medium term) compared with risperidone (very low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life Short Form 12 Health Survey (SF‐12) · people with ALS/MND
1 finding from 1 review
Clinical response: mean score/change in global state: mean CGI score (high = poor) Short term (8 weeks) · people with treatment‐resistant schizophrenia
1 finding from 1 review
Global state: Response ‐ proxy outcome ‐ mental state: 1. General ‐ average score (Brief Psychiatric Rating Scale by over 24 weeks · people with treatment‐resistant schizophrenia
1 finding from 1 review